|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Escitalopram
Efficacy and safety of Aripiprazole as adjunctive therapy in major ... - 25 May 2007 News-Medical.net,The ADTs included escitalopram, fluoxetine, paroxetine controlled release, sertraline or venlafaxine extended release, dosed per label guidelines.
Brain scan can predict response to antidepressants - May 21, 2007 New Scientist (subscription),...to measure the electrical activity in the frontal lobes of 111 patients who had been on the antidepressant drug Lexapro (escitalopram) for a week.
BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for ... - May 21, 2007 PR Newswire (press release),Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance
Analysis Group to Present New Research at International Society ... - May 21, 2007 PharmaLive.com (press release),The study found that patients initiated on escitalopram (Lexapro) have better treatment compliance, fewer hospitalization days, and lower health care costs.
Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure ... - May 21, 2007 PR-Inside.com (Pressemitteilung),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment
BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for ... - May 21, 2007 PR Newswire (press release),About Forest Laboratories and Its Products Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant
Earnings shoot up at Denmark's Lundbeck as Lexapro sales soar - May 10, 2007 Pharma Times (subscription),...sales of the active pharmaceutical ingredient for Lexapro (escitalopram) to US licensee Forest Laboratories, which was reducing its inventories.
Antidepressant Data Review Finds Benefits Trump Risks - May 4, 2007 Psychiatric News,Antidepressants used in the trials were nefazodone, venlafa xine, mirtazepine, paroxetine, sertraline, citalopram, escitalopram, fluoxetine, and fluvoxamine
Interim report for the first quarter - May 8, 2007 Ad-Hoc-News (Pressemitteilung),Lundbeck firmly believes that the Group's intellectual propertyrights concerning escitalopram are valid and enforceable, and it isstill our policy to
Study of drug therapy for compulsive buying yields a puzzle ... - Mar 30, 2007 exduco.net,The medication is escitalopram, a commonly prescribed antidepressant sold under the brand name Lexapro. In the study, researchers found no difference in the
Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter ... - Apr 24, 2007 PR-Inside.com (Pressemitteilung),Sales of Lexapro(R) (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal ... - Apr 12, 2007 Drug Newswire (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment
Eli Lilly sues Sun Pharma over patent - Apr 1, 2007 Business Standard,...demanding to allow launch of its generic version of anxiety and depression drug Lexapro, known generically as escitalopram oxalate.
Merck & Co and Lundbeck's sleep drug terminated in Phase III - Mar 29, 2007 Pharma Times (subscription),...which many hoped would reduce the firm's reliance on the antidepressant Cipralex/Lexapro (escitalopram oxalate), which accounted for almost two-thirds
Coach's son enters drug rehab - Feb 17, 2007 Biloxi Sun Herald,Police said they also found a variety of pills in the vehicle, including amphetamines and Escitalopram, which is used to treat depression.
Eagles Coach's Son Expected to Surrender - Feb 16, 2007 San Francisco Chronicle,...that were amphetamines; the over-the-counter pain reliever acetaminophen; and Escitalopram, which is used to treat depression, the complaint states.
Garrett Reid surrenders to police - Feb 16, 2007 Cherry Hill Courier Post,...police also found a variety of pills in his Jeep that proved to be amphetamines, the over-the-counter pain reliever acetaminophen, and Escitalopram,
Sepracor Announces Fourth Quarter and Full Year 2006 Results - Jan 31, 2007 Business Wire (press release),Patients with insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg, which is approved for the treatment of GAD,
Sepracor Announces Fourth Quarter and Full Year 2006 Results - Jan 31, 2007 Genetic Engineering News (press release),Patients with insomnia and GAD were randomized to receive nightly LEXAPRO(R) brand escitalopram oxalate 10 mg, which is approved for the treatment of GAD,
Consumer Alert for Internet Drugs - Feb 22, 2007 Facts and Comparisons,Orders placed on the Internet for Ambien (zolpidem tartrate), Xanax (alprazolam), Lexapro (escitalopram oxalate), and Ativan (lorazepam) contained
Unsafe, Misrepresented Drugs Purchased Over the Internet: Ambien ... - Feb 19, 2007 DG NewsBETHESDA, MD -- February 19, 2007 -- FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications
Reid Son Arraigned For Drug Possession - Feb 17, 2007 Chester Daily Local Online,Laboratory tests determined the pills were amphetamines, acetaminophen, testosterone and escitalopram, a drug used to treat depression.
Andy Reid's oldest son in drug-treatment program - Feb 17, 2007 Cherry Hill Courier Post,Police said they also found a variety of pills in the vehicle, including amphetamines and escitalopram, which is used to treat depression.
Reid's other son charged with drug violations - Feb 15, 2007 San Jose Mercury News,A search of Reid's SUV found 22 capsules later identified as acetaminophen, amphetamines, and the depression medication escitalopram, according to court
Forest Laboratories Announces Rule 144 Sale by Executive Officer - Feb 15, 2007 Drug Newswire (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment
FDA Panel Seeks to Balance Risks in Warnings for Antidepressants - Feb 13, 2007 Journal of American Medical Association (subscription),Both analyses, which examined data from trials of bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazadone,
Forest Laboratories Announces Termination of Agreement for Faropenem - Feb 6, 2007 Yahoo! News (press release)Forest Laboratories' growing product line includes Lexapro® (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment
Funding can depend on where you live - Feb 5, 2007 ic Wales,Escitalopram for generalised anxiety disorder to replace venlafaxine, which had been restricted in December 2004. DesmoMelts, an anti-diuretic,
Which Antidepressant is Right for You? - Feb 1, 2007 Ivanhoe,...antidepressants: bupropion (Wellbutrin), citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox),
Efficacy Similar Among Antidepressants, Side Effects Drive ... - Jan 29, 2007 Science Daily (press release)The drugs reviewed were bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline,
Newer Class Of Antidepressants Similar In Effectiveness, Side ... - Jan 29, 2007 Medical News Today (press release),...citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (formerly sold as Luvox), mirtazapine (Remeron),
Alcohol Use and Anxiety: Diagnostic and Management Issues - Jan 31, 2007 Am J Psychiatry (subscription)In addition to cognitive behavior therapy targeting both alcohol relapse prevention and social anxiety, Ms. M was started on escitalopram (10 mg/day),
Cipralex Approved in Europe for the Treatment of Obsessive ... - 18 Jan 2007 Earthtimes.orgCOPENHAGEN, Denmark, January 18 -- H. Lundbeck A/S is pleased to announce the approval of Cipralex(R) (escitalopram) in Europe for the treatment of
Lundbeck's Cipralex gets EU green light for OCD - Jan 15, 2007 Pharma Times (subscription),The approval is based on a 24-week study involving more than 750 patients, which demonstrated that 10mg and 20mg of Cipralex (escitalopram) is an effective
Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share ... - Jan 16, 2007 Drug Newswire (press release),Sales in the quarter included $554964000 for Forest's antidepressant franchise which was comprised of $545855000 of Lexapro(R) (escitalopram oxalate),
Lundbeck's Cipralex approved in EU for treating obsessive ... - Jan 12, 2007 Forbes,COPENHAGEN (AFX) - H Lundbeck AS said its Cipralex drug (escitalopram) has received EU approval for the treatment of obsessive compulsive disorder (OCD).
Lexapro and Namenda push Forest Labs earnings up 28 - Jan 17, 2007 Pharma Times (subscription),Turnover for the quarter was up 18% to just over $893 million, with sales of Lexapro (escitalopram) climbing 14% to $545.9 million, while Namenda
Danish shares close up led by AP Moeller, FLSmidth; TrygVesta, DSV ... - Jan 12, 2007 Forbes,The group's Cipralex drug (escitalopram) has received EU approval for the treatment of obsessive compulsive disorder (OCD). Carlsberg B was unchanged at 561
Cipralex® approved for the treatment of obsessive compulsive ... - Jan 12, 2007 WebWire (press release),12-01-2007 - Today, Cipralex® (escitalopram) has been approved in the EU for the treatment of obsessive compulsive disorder (OCD) by the Swedish Medical
Forest Laboratories Announces Completion of Acquisition of Cerexa ... - Jan 12, 2007 PharmaLive.com (press release),Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the internal and maintenance
Exacerbation of Psychogenic Movement Disorder by Interferon ... - Jan 5, 2007 Psychosomatics (subscription)We switched antidepressant therapy to escitalopram and increased the dosage to 20 mg/day. We added psychotherapeutic treatment in single and group settings.
Affective Disorder and Personality Change in a Patient With ... - Jan 5, 2007 Psychosomatics (subscription)Adjustment of valproate and the addition of escitalopram oxalate did not help these symptoms. However, he has benefited from regular cognitive-behavioral
The Antidepressant Quandary — Considering Suicide Risk When ... - Dec 27, 2006 New England Journal of Medicine (subscription),...citalopram (Celexa), escitalopram (Lexapro), bupropion (Wellbutrin), venlafaxine (Effexor), nefazodone (Serzone), and mirtazapine (Remeron).
Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ... - Dec 5, 2006 DG NewsIn this study, patients who met DSM-IV®(1) criteria for both insomnia and GAD were randomized to receive nightly Lexapro® brand escitalopram oxalate 10 mg ...
Data Show Sepracor's Lunesta ® Improved Insomnia in Patients with ... - Dec 5, 2006 Business Wire (press release),In this study, patients who met DSM-IV ®1 criteria for both insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg ...
Lexapro(R) Demonstrated Significance On Prospectively Defined ... - Dec 7, 2006 Medical News Today (press release),Forest Laboratories, Inc., (NYSE: FRX) today announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided a greater ...
Lexapro Demonstrated Significance on Prospectively Defined ... - Dec 6, 2006 PharmaLive.com (press release),2006 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc., today announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided ...
Forest Laboratories Announces Acquisition of Cerexa, Inc. - Dec 14, 2006 Yahoo! News (press release)Forest Laboratories' growing product line includes Lexapro® (escitalopram oxalate), an SSRI indicated for adults for the internal and maintenance treatment of ...
Forest boosts pipeline with $480 million buy of Cerexa - Dec 15, 2006 Pharma Times (subscription),Forest's flagship product is the antidepressant Lexapro (escitalopram), which has patent protection until 2012, despite a recent patent challenge by Teva, and ...
Lundbeck says Lexapro depression treatment better tolerated than ... - Dec 6, 2006 Forbes,Laboratories Inc today announced the results of a new head-to-head study of Lundbeck's depression treatment, Lexapro/Cipralex (escitalopram oxalate), against ...
Continuing medication fights depression - Dec 4, 2006 Victoria Times Colonist,VCU psychiatry professor Susan Kornstein reported after a study of 200 patients over three years that maintenance treatment with escitalopram, a selective ...
ADAC: Canadians Struggle to Get Adequate Treatment for Anxiety ... - Dec 6, 2006 CCNMatthews (press release),The selective serotonin reuptake inhibitors (SSRI's) such as paroxetine (Paxil), sertraline (Zoloft), citalopram (Celexa), and escitalopram (Cipralex) have ...
Lexapro®/Cipralex® demonstrated significance on prospectively ... - Dec 6, 2006 WebWire (press release),...today announced the results of a new head to head study of Lexapro®/Cipralex® (escitalopram oxalate) versus Cymbalta® (duloxetine). ...
Forest Laboratories (FRX) Announces New Study Results for Lexapro - Dec 6, 2006 StreetInsider.com (subscription),Forest Laboratories, Inc., (NYSE: FRX) announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided a greater reduction in ...
Long-term anti-depressants may help some Nov 7, 2006 ...who switched to placebo showed a significantly higher rate of depression recurrence -- 65 percent, compared to those who stayed on escitalopram -- 27 percent ... -United Press International
Psychiatric Pharmacogenomics Oct 20, 2006 Other antidepressant medications such as escitalopram and fluvoxamine are minimally metabolized by the 2D6 enzyme and would be expected to be well tolerated by ... -Focus (subscription)
Forest Laboratories Reports Earnings Per Share of $0.75 for Q2'07 Oct 17, 2006 Sales in the quarter included $522,662,000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, an increase ... -MSN Money
Comparative effectiveness of second-generation antipsychotics and ... Oct 31, 2006 ...lamotrigine 2 patients, oxcarbazepine 2 patients, carbamazepine 1 patient), antidepressant (sertraline 3 patients, bupropion 1 patient, escitalopram 1 patient ... -British Journal of Psychiatry (subscription),
Patient Recruitment For Desmoteplase Phase IIB/III Stroke Study ... Oct 26, 2006 Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... -Medical News Today (press release),
Escitalopram Helps Prevents Relapses of Obsessive-Compulsive ... Sep 18, 2006 PARIS, FRANCE -- September 18, 2006 -- Escitalopram, a highly selective serotonin reuptake inhibitor (SSRI), significantly prevents relapses compared with ... -DG News
DATA PRESENTED INDICATES ESCITALOPRAM MAY BE A PROMISING FUTURE ... Sep 19, 2006 PARIS, France, September 19 /PRNewswire/ -- New data presented today demonstrates that escitalopram is efficacious and well tolerated in the treatment of ... -ITNews
Escitalopram and paroxetine in the treatment of generalised ... Aug 31, 2006 Aims To assess the efficacy of different doses of escitalopram in generalised anxiety disorder. Method Randomised, double-blind, placebo ... -British Journal of Psychiatry (subscription)
Escitalopram for Major Depression in Parkinson’s Disease: An ... Sep 8, 2006 ...established. The authors treated 14 Parkinson’s disease patients with major depression with escitalopram in an open-label study. ... -Journal of Neuropsychiatry (subscription)
(PRN) - Medical Broadcasting Company Hires Navarrow Wright to Lead ... Sep 19, 2006 ...[+]. (PRN) - Data Presented Indicates Escitalopram may be a Promising Future Treatment Option in Obsessive Compulsive Disorder ... [+. ... -Bolsamania.com
Adjunctive Risperidone Effective for Treatment-Resistant Major ... Sep 22, 2006 ...vs 0.7%), trazodone (0.8% vs 1.5%), venlafaxine (18.3% vs 21.9%), and other (6.9% vs 1.5%); and the SSRIs citalopram (6.1% vs 2.9%), escitalopram (19.1% vs 16.1 ... -DG News
Controversial Efficacy of SSRIs in Children and Adolescents ... Sep 19, 2006 ...randomisation, SSRI treatments included paroxetine (n = 447), fluoxetine (n = 287), citalopram (n = 217), sertraline (n = 189) and escitalopram (n = 132). ... -DG News
Hyponatremia associated with SSRI antidepressants in older adults Sep 3, 2006 Selective serotonin reuptake inhibitors are used to treat depression and anxiety; SSRIs include: Citalopram ( Celexa ), Escitalopram ( Lexapro ), Fluoxetine ... -Xagena.it
Highlights of this issue Aug 31, 2006 264-272) report that escitalopram is an effective treatment for generalised anxiety disorder, with no significant difference between the 10 mg and 20 mg doses ... -British Journal of Psychiatry (subscription)
Treatment of Depressive Syndrome in Alzheimer’s Disease, Aug 25, 2006 The goal of the present study is to compare the effectiveness of the active (S)-enantiomer of citalopram, escitalopram with placebo in the treatment of ... -Community Dispatch
Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. ... Sep 7, 2006 Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... -PR Newswire
Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ... - Dec 5, 2006 DG NewsIn this study, patients who met DSM-IV®(1) criteria for both insomnia and GAD were randomized to receive nightly Lexapro® brand escitalopram oxalate 10 mg,
Data Show Sepracor's Lunesta ® Improved Insomnia in Patients with ... - Dec 5, 2006 Business Wire (press release),In this study, patients who met DSM-IV ®1 criteria for both insomnia and GAD were randomized to receive nightly LEXAPRO ® brand escitalopram oxalate 10 mg,
Lexapro(R) Demonstrated Significance On Prospectively Defined ... - Dec 7, 2006 Medical News Today (press release),Lexapro is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs), pimozide, or in patients with a hypersensitivity to escitalopram oxalate
Lexapro curbs risk of recurrent depression - Nov 17, 2006 CNN..."Escitalopram is another treatment option that has now been shown to be effective for maintenance treatment of major depressive disorder," Dr. Susan G.
H.Lundbeck A/SInterim report for the third quarter of 2006 - Nov 15, 2006 PharmaLive.com (press release),Revenue from the USA amounted to DKK 482 million, a decline of 21% (18% decrease at CER), due to lower supplies of bulk escitalopram to Forest as part of
Continuing medication fights depression - Dec 4, 2006 Victoria Times Colonist,VCU psychiatry professor Susan Kornstein reported after a study of 200 patients over three years that maintenance treatment with escitalopram,
New Treatment Strategy For The Prevention Of Recurrent Depression - Nov 15, 2006 Science Daily (press release)This was followed by four months of treatment with escitalopram. These participants were then randomly assigned to fixed-dose treatment with 10 or 20 mg of
Lundbeck retains FY guidance as Q3 earnings beat consensus UPDATE - Nov 15, 2006 Forbes,However, the continued reduction of escitalopram inventories by US partner Forest Laboratories led to a 21 pct year-on-year decline in income from Lexapro
Ben Hays Hi There Hi There - Nov 14, 2006 Digital Divide Network,...testified for a drug for over these drugs that sell lexapro escitalopram as stearic acid, and less than the drugs phentermine the fingers and the
Lundbeck says Lexapro depression treatment better tolerated than ... - Dec 6, 2006 Forbes,...depression treatment, Lexapro/Cipralex (escitalopram oxalate), against Cymbalta (duloxetine), a depression treatment made by Eli Lilly and Co.
Lexapro®/Cipralex® demonstrated significance on prospectively ... - Dec 6, 2006 WebWire (press release),Inc. today announced the results of a new head to head study of Lexapro®/Cipralex® (escitalopram oxalate) versus Cymbalta® (duloxetine).
Forest Laboratories (FRX) Announces New Study Results for Lexapro - Dec 6, 2006 StreetInsider.com (subscription),Forest Laboratories, Inc., (NYSE: FRX) announced the results of a new study demonstrating that Lexapro (escitalopram oxalate) provided a greater reduction
ADAC: Canadians Struggle to Get Adequate Treatment for Anxiety ... - Dec 6, 2006 CCNMatthews (press release),The selective serotonin reuptake inhibitors (SSRI's) such as paroxetine (Paxil), sertraline (Zoloft), citalopram (Celexa), and escitalopram (Cipralex) have
Lundbeck profit up 3% on lower costs, Cipralex sales - Nov 14, 2006 MarketWatchForest Laboratories in February decided to reduce its inventory of escitalopram, the active ingredient in the Lundbeck antidepressant Lexapro, reducing the
Interim Report for the Second Quarter of 2006 Aug 16, 2006 ...affected by Forest Laboratories, Inc. reduction of in-house escitalopram inventories in 2006. Second-quarter consolidated revenue ... -PharmaLive.com
Treatment of Depressive Syndrome in Alzheimer’s Disease, Aug 25, 2006 The goal of the present study is to compare the effectiveness of the active (S)-enantiomer of citalopram, escitalopram with placebo in the treatment of ... -Community Dispatch
Lundbeck shares slip as profits slide Aug 16, 2006 ...in profit had been expected after Lundbeck warned of declining sales of the active pharmaceutical ingredient (API) for Lexapro (escitalopram oxalate) to US ... -Pharma Times (subscription)
Lundbeck still sees FY opg of 1.6 bln dkr as H1 earnings below ... Aug 16, 2006 The year-on-year decline in sales should be seen in light of the reduction of escitalopram inventories at Lundbeck's US partner, Forest Laboratories Inc, which ... -Forbes
New Biologic Tools in Psychiatry Aug 23, 2006 This enzyme metabolizes psychotropics such as amitriptyline, clomipramine, citalopram, escitalopram, sertraline, and diazepam: 2% to 4% of whites, 10% to 25 ... -Psychiatric Times
Pregnancy: newer antidepressants linked to persistent pulmonary ... Aug 16, 2006 ...for the treatment of depression include the following drugs: Wellbutrin ( Bupropion ), Celexa ( Citalopram ), Cipralex ( Escitalopram ), Prozac ( Fluoxetine ... -Xagena.it
Anti-depression drugs a risk to migraine sufferers Jul 28, 2006 Zoloft and Arrow's Xydep), citalopram (Alphapharm's Celapram, Lundbeck's Cipramil, Arrow's Talam and Hexal's Talohexal), escitalopram (Lundbeck's Lexapro) and ... -The Australian
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|